Literature DB >> 8707098

Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.

F W Leebeek1, R J Ouwendijk, A H Kolk, A Dees, J C Meek, J E Nienhuis, A M Dingemans-Dumas.   

Abstract

BACKGROUND: Bladder instillations with Bacillus Calmette-Guerin (BCG) are commonly used as immunotherapy for bladder carcinoma. Sometimes patients experience serious systemic side effects, such as sepsis or pneumonitis. Granulomatous hepatitis is a rare serious side effect, which has been considered a hypersensitivity reaction to BCG. PATIENT: The first case of granulomatous hepatitis after BCG bladder instillation in which mycobacteria were identified by staining techniques and mycobacterial DNA was detected in liver tissue using the polymerase chain reaction is reported.
CONCLUSION: The granulomatous hepatitis was caused by BCG infection of the liver after haematogenous dissemination of BCG, rather than hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707098      PMCID: PMC1383125          DOI: 10.1136/gut.38.4.616

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Granulomatous hepatitis following intravesical BCG therapy.

Authors:  D Thompson; J Cumming
Journal:  Br J Urol       Date:  1990-10

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 3.  Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview.

Authors:  J A Witjes; A P vd Meijden; F M Debruyne
Journal:  Urol Int       Date:  1990       Impact factor: 2.089

4.  Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma.

Authors:  H Y Marans; H M Bekirov
Journal:  J Urol       Date:  1987-01       Impact factor: 7.450

5.  Detection of Mycobacterium tuberculosis in clinical samples by using polymerase chain reaction and a nonradioactive detection system.

Authors:  A H Kolk; A R Schuitema; S Kuijper; J van Leeuwen; P W Hermans; J D van Embden; R A Hartskeerl
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

6.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

7.  Mycobacterium smegmatis strain for detection of Mycobacterium tuberculosis by PCR used as internal control for inhibition of amplification and for quantification of bacteria.

Authors:  A H Kolk; G T Noordhoek; O de Leeuw; S Kuijper; J D van Embden
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.

Authors:  D D Proctor; S Chopra; S C Rubenstein; J A Jokela; L Uhl
Journal:  Am J Gastroenterol       Date:  1993-07       Impact factor: 10.864

9.  Systemic bacillus Calmette-Guérin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer.

Authors:  A Steg; C Leleu; B Debré; L Boccon-Gibod; D Sicard
Journal:  Eur Urol       Date:  1989       Impact factor: 20.096

10.  Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy.

Authors:  C McParland; D J Cotton; K S Gowda; V H Hoeppner; W T Martin; P F Weckworth
Journal:  Am Rev Respir Dis       Date:  1992-11
View more
  14 in total

1.  Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report.

Authors:  Cindy Q Gao; Rozina Mithani; Jack Leya; Lesley Dawravoo; Arvin Bhatia; John Antoine; Felipe De Alba; Peter A Russo; Claus J Fimmel
Journal:  BMC Infect Dis       Date:  2011-09-30       Impact factor: 3.090

Review 2.  Bladder cancer in the elderly.

Authors:  Shahrokh F Shariat; Matthew Milowsky; Michael J Droller
Journal:  Urol Oncol       Date:  2009 Nov-Dec       Impact factor: 3.498

3.  "BCGitis": A rare case of tuberculous epididymo-orchitis following intravesical Bacillus Calmette-Guérin therapy.

Authors:  Virginie Demers; Vincent Pelsser
Journal:  J Radiol Case Rep       Date:  2012-11-01

4.  [Sepsis and multiple organ failure after BCG-instillation for bladder cancer].

Authors:  A Elmer; U Bermes; L Drath; E Büscher; A Viertel
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

5.  Hepatic granulomas: a 10 year single centre experience.

Authors:  D R Gaya; D Thorburn; K A Oien; A J Morris; A J Stanley
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

Review 6.  The effect of age and gender on bladder cancer: a critical review of the literature.

Authors:  Shahrokh F Shariat; John P Sfakianos; Michael J Droller; Pierre I Karakiewicz; Siegfried Meryn; Bernard H Bochner
Journal:  BJU Int       Date:  2009-11-13       Impact factor: 5.588

Review 7.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

8.  Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.

Authors:  Aliye Soylu; Ali T Ince; Hakan Polat; Nurgul Yasar; Aydin Ciltas; Selvinaz Ozkara; Ali I Tasci
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-04-15       Impact factor: 3.944

9.  A Case of Systemic Toxicity Related to Intravesical Bacillus Calmette-Guerin for the Treatment of Bladder Cancer.

Authors:  Sachin Gupta; Balraj Singh; Harshil Bhatt; Sandeep Singh; Sorab Gupta
Journal:  Cureus       Date:  2021-05-29

10.  Granulomatous Hepatitis Following Intra-Vesical Instillation of Bacillus Calmette-Guérin for Treatment of Bladder Cancer.

Authors:  Elsa Alves Branco; Raquel Duro; Teresa Brito; António Sarmento
Journal:  Infect Dis Rep       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.